MedTrace Logo

A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA

NCT00652925 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2008-05-30

No results posted yet for this study

Summary

To study Celebrex versus naproxen to see if it decreases symptoms of juvenile arthritis such as pain and swelling.

Conditions

  • Arthritis, Juvenile Rheumatoid

Interventions

DRUG

Celecoxib

Higher dose, 6 mg/kg/dose BID

DRUG

Celecoxib

Active drug at lower dose

DRUG

Naproxen

Control comparator, 15 mg/kg/dy target dose

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-31
Primary Completion
2004-04-30
Completion
2005-04-30

Countries

  • United States
  • Belgium
  • Brazil
  • Canada
  • Denmark
  • France
  • Germany
  • Mexico
  • Peru
  • Portugal
  • Russia
  • Slovakia
  • Slovenia
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00652925 on ClinicalTrials.gov